Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Twenty years of follow-up among survivors of childhood and young adult acute myeloid leukemia: a report from the Childhood Cancer Survivor Study.

Mulrooney DA, Dover DC, Li S, Yasui Y, Ness KK, Mertens AC, Neglia JP, Sklar CA, Robison LL, Davies SM; Childhood Cancer Survivor Study.

Cancer. 2008 May 1;112(9):2071-9. doi: 10.1002/cncr.23405.

PMID:
18327823
[PubMed - indexed for MEDLINE]
Free Article
2.

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.

Miser JS, Goldsby RE, Chen Z, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore SG, Rausen AR, Vietti TJ, Grier HE.

Pediatr Blood Cancer. 2007 Dec;49(7):894-900.

PMID:
17584910
[PubMed - indexed for MEDLINE]
3.

Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.

Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS, Grier HE, Link MP, Meyers PA, Perlman EJ, Rausen AR, Robison LL, Vietti TJ, Miser JS.

Blood. 2007 Jan 1;109(1):46-51. Epub 2006 Sep 19.

PMID:
16985182
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

Miser JS, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Grier HE.

J Clin Oncol. 2004 Jul 15;22(14):2873-6.

PMID:
15254055
[PubMed - indexed for MEDLINE]
Free Article
5.

Phase 1 study of Paclitaxel administered twice weekly to children with refractory solid tumors: a pediatric oncology group study.

Hayashi RJ, Blaney S, Sullivan J, Weitman S, Vietti T, Bernstein ML; Pediatric Oncology Group Study.

J Pediatr Hematol Oncol. 2003 Jul;25(7):539-42.

PMID:
12847320
[PubMed - indexed for MEDLINE]
6.

Phase I trial of rebeccamycin analog (NSC #655649) in children with refractory solid tumors: a pediatric oncology group study.

Langevin AM, Weitman SD, Kuhn JG, Weintraub ST, Baruchel S, Furman W, Bernstein M, Blaney S, Vietti T; Pediatric Oncology Group Study.

J Pediatr Hematol Oncol. 2003 Jul;25(7):526-33.

PMID:
12847318
[PubMed - indexed for MEDLINE]
7.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS.

N Engl J Med. 2003 Feb 20;348(8):694-701.

PMID:
12594313
[PubMed - indexed for MEDLINE]
Free Article
8.

Protracted intermittent schedule of topotecan in children with refractory acute leukemia: a pediatric oncology group study.

Furman WL, Stewart CF, Kirstein M, Kepner JL, Bernstein ML, Kung F, Vietti TJ, Steuber CP, Becton DL, Baruchel S, Pratt C.

J Clin Oncol. 2002 Mar 15;20(6):1617-24.

PMID:
11896112
[PubMed - indexed for MEDLINE]
9.

Old man river. The flow of pediatric oncology.

D'Angio GJ, Vietti TJ.

Hematol Oncol Clin North Am. 2001 Aug;15(4):599-607, vii. Review.

PMID:
11676275
[PubMed - indexed for MEDLINE]
10.

Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study.

Saylors RL 3rd, Stine KC, Sullivan J, Kepner JL, Wall DA, Bernstein ML, Harris MB, Hayashi R, Vietti TJ; Pediatric Oncology Group.

J Clin Oncol. 2001 Aug 1;19(15):3463-9.

PMID:
11481351
[PubMed - indexed for MEDLINE]
11.

Up-front window trial of topotecan in previously untreated children and adolescents with metastatic rhabdomyosarcoma: an intergroup rhabdomyosarcoma study.

Pappo AS, Lyden E, Breneman J, Wiener E, Teot L, Meza J, Crist W, Vietti T.

J Clin Oncol. 2001 Jan 1;19(1):213-9.

PMID:
11134215
[PubMed - indexed for MEDLINE]
12.

Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation.

Thomas PR, Deutsch M, Kepner JL, Boyett JM, Krischer J, Aronin P, Albright L, Allen JC, Packer RJ, Linggood R, Mulhern R, Stehbens JA, Langston J, Stanley P, Duffner P, Rorke L, Cherlow J, Friedman HS, Finlay JL, Vietti TJ, Kun LE.

J Clin Oncol. 2000 Aug;18(16):3004-11.

PMID:
10944134
[PubMed - indexed for MEDLINE]
13.

Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study.

Bernstein ML, Baruchel S, Devine S, Markoglou N, Wainer IW, Williams M, Blaney S, Moghrabi A, Winick N, Vietti T.

J Pediatr Hematol Oncol. 1999 Nov-Dec;21(6):494-500.

PMID:
10598660
[PubMed - indexed for MEDLINE]
14.

Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience.

Navid F, Mosijczuk AD, Head DR, Borowitz MJ, Carroll AJ, Brandt JM, Link MP, Rozans MK, Thomas GA, Schwenn MR, Shields DJ, Vietti TJ, Pullen DJ.

Leukemia. 1999 Jan;13(1):135-41.

PMID:
10049049
[PubMed - indexed for MEDLINE]
15.

Phase I trial of 9-aminocamptothecin in children with refractory solid tumors: a Pediatric Oncology Group study.

Langevin AM, Casto DT, Thomas PJ, Weitman SD, Kretschmar C, Grier H, Pratt C, Dubowy R, Bernstein M, Blaney S, Vietti T.

J Clin Oncol. 1998 Jul;16(7):2494-9.

PMID:
9667269
[PubMed - indexed for MEDLINE]
16.

Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study.

Saylors RL 3rd, Stewart CF, Zamboni WC, Wall DA, Bell B, Stine KC, Vietti TJ.

J Clin Oncol. 1998 Mar;16(3):945-52.

PMID:
9508177
[PubMed - indexed for MEDLINE]
17.

Conduct of phase I trials in children with cancer.

Smith M, Bernstein M, Bleyer WA, Borsi JD, Ho P, Lewis IJ, Pearson A, Pein F, Pratt C, Reaman G, Riccardi R, Seibel N, Trueworthy R, Ungerleider R, Vassal G, Vietti T.

J Clin Oncol. 1998 Mar;16(3):966-78.

PMID:
9508179
[PubMed - indexed for MEDLINE]
18.

Pediatric phase II cancer chemotherapy trials: a Pediatric Oncology Group study.

Weitman S, Ochoa S, Sullivan J, Shuster J, Winick N, Pratt C, Vietti T, Harris M.

J Pediatr Hematol Oncol. 1997 May-Jun;19(3):187-91.

PMID:
9201138
[PubMed - indexed for MEDLINE]
19.

Preservation of the bladder in patients with rhabdomyosarcoma.

Heyn R, Newton WA, Raney RB, Hamoudi A, Bagwell C, Vietti T, Wharam M, Gehan E, Maurer HM.

J Clin Oncol. 1997 Jan;15(1):69-75.

PMID:
8996126
[PubMed - indexed for MEDLINE]
20.

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study.

Tubergen DG, Stewart CF, Pratt CB, Zamboni WC, Winick N, Santana VM, Dryer ZA, Kurtzberg J, Bell B, Grier H, Vietti TJ.

J Pediatr Hematol Oncol. 1996 Nov;18(4):352-61.

PMID:
8888741
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk